03415nam 22006851 450 991081297420332120120628124337.01-84731-909-21-4742-0077-X1-283-53952-797866138519701-84731-908-410.5040/9781474200776(CKB)2560000000090539(EBL)990457(OCoLC)805517578(SSID)ssj0000701503(PQKBManifestationID)12261547(PQKBTitleCode)TC0000701503(PQKBWorkID)10676040(PQKB)11509513(MiAaPQ)EBC1772924(MiAaPQ)EBC990457(Au-PeEL)EBL1772924(CaPaEBR)ebr10589790(CaONFJC)MIL385197(OCoLC)893332401(OCoLC)809536917(UtOrBLW)bpp09259369(MiAaPQ)EBC6164402(Au-PeEL)EBL990457(EXLCZ)99256000000009053920150827d2012 uy 0engur|n|---|||||txtccrLaw and the regulation of medicines /Emily Jackson1st ed.Oxford ;Portland, Ore. :Hart Publishing,2012.1 online resource (308 p.)Description based upon print version of record.1-84946-179-1 Includes bibliographical references (pages 267-292).What are medicines and why are they special? -- Clinical trials -- Licensing -- Pharmacovigilance and liability for dangerous drugs -- Marketing -- Funding and access to medicines in the UK -- Funding and access to medicines : a global problem -- The future of medicines I : pharmacogenetics -- The future of medicines II : enhancement."The principal purpose of this book is to tell the story of a medicine's journey through the regulatory system in the UK, from defining what counts as a medicine, through clinical trials, licensing, pharmacovigilance, marketing and funding. The question of global access to medicines is addressed because of its political importance, and because it offers a particularly stark illustration of the consequences of classifying medicines as a private rather than a public good. Two further specific challenges to the future of medicine's regulation are examined separately: first, pharmacogenetics, or the genetic targeting of medicines to subgroups of patients, and second, the possibility of using medicines to enhance well-being or performance, rather than treat disease. Throughout, the emphasis is on the role of regulation in shaping and influencing the operation of the medicines industry, an issue that is of central importance to the promotion of public health and the fair and equitable distribution of healthcare resources."--Bloomsbury Publishing.DrugsLaw and legislationGreat BritainPharmacyLaw and legislationGreat BritainMedical & healthcare lawDrugsLaw and legislationPharmacyLaw and legislation344.410416Jackson Emily1966-1496592UtOrBLWUtOrBLWBOOK9910812974203321Law and the regulation of medicines3953573UNINA